Form 4: Clene Inc. Insider Divests Shares via SymBiosis II, LLC

Reporting person Chidozie Ugwumba sold a total of 39,162 shares of Clene Inc. common stock across three transactions in April 2026.

Summary

• Chidozie Ugwumba, a 10% owner of Clene Inc., executed a series of sales of common stock held by SymBiosis II, LLC.
• The sales occurred between April 15, 2026, and April 17, 2026.
• A total of 39,162 shares were sold at prices ranging from $6.40 to $6.48 per share.
• Following these transactions, the reporting person maintains beneficial ownership of 362,729 shares through SymBiosis II, LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the filing represents routine insider activity rather than a fundamental change in company strategy or financial performance.

Positives

• The transactions were executed in the open market, providing liquidity for the reporting entity.

Negatives

• The sale of shares by a 10% owner may be perceived by the market as a lack of confidence in the short-term price appreciation of the stock.

Risks

• Continued divestment by major shareholders could exert downward pressure on the stock price.

Future Outlook

No specific forward-looking guidance or operational outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that insider selling by significant shareholders is a common occurrence for portfolio rebalancing or liquidity needs and does not necessarily reflect the fundamental health of the underlying biotechnology firm.

Comparison to Industry Standards

• Insider transactions are standard regulatory disclosures for biotech firms and do not deviate from typical corporate governance reporting requirements.

Related Party Transactions

• The shares are held by SymBiosis II, LLC, an entity associated with the reporting person.

Stakeholder Impact

• Shareholders may monitor these sales for potential signals regarding the long-term outlook of the company held by major investors.

Next Steps

• Continued monitoring of Form 4 filings to track further changes in beneficial ownership by major shareholders.

Key Dates

Keywords

Clene Inc, CLNN, Insider Trading, Form 4, SymBiosis II, Chidozie Ugwumba